The Case for Opt-Out BBV Testing
Author: Margaret R. Moreland, J.D., M.S.L.S..
Source: Volume 20, Number 04, May/June 2019 , pp.63-64(2)

< previous article |next article > |return to table of contents
Abstract:
The Centers for Disease Control and Prevention has recommended opt-out HIV testing within the high-risk environment of U.S. correctional facilities. It has already been established that opt-out BBV testing is effective for case detection prisons, where drug dependency has elevated the prevalence of BBV infections. However, there is considerable variation in the way opt-out BBV test programs have been implemented and in their outcomes. More research is needed to explain these outcome variations. This review summarizes the findings in “Understanding How, Why, for Whom, and Under What Circumstances Opt-Out Bloodborne Virus Testing Programmes Work to Increase Test Engagement and Uptake within Prison: A Rapid-Realist Review” by Seth Francis-Graham, Nnenna Adaniya Ekeke, Corey Andrew Nelson, Tin Yan Lee, Sulaima El Haj, Tim Rhodes, Cecilia Vindrola, Tim Colbourn and William Rosenberg, published in 19 BMC Health Services Research 152 (2019).Keywords: Opt-Out Bloodborne Virus Testing
Affiliations:
1: Pace University School of Law.